NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Stock Ownership - Who owns Tonix Pharmaceuticals Holding?

Insider buying vs selling

Have Tonix Pharmaceuticals Holding Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Seth LedermanChief Executive Officer2025-05-154,000$21.55
$86.20kBuy
Seth LedermanChief Executive Officer2025-02-055$3.38
$16.90Sell

1 of 1

TNXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNXP insiders and whales buy or sell their stock.

TNXP Shareholders

What type of owners hold Tonix Pharmaceuticals Holding Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Lederman66.72%5,848,521$234.35MInsider
Lederman Co LLC42.12%3,692,558$147.96MInsider
David J. Moss37.08%3,250,000$130.23MInsider
Stuart Davidson18.50%1,621,622$64.98MInsider
Donald W. Landry7.51%658,348$26.38MInsider
Blackrock Inc4.80%420,448$16.85MInstitution
Geode Capital Management LLC2.00%175,212$7.02MInstitution
Bruce Daugherty1.89%165,777$6.64MInsider
Vanguard Group Inc1.88%164,732$6.60MInstitution
Northern Trust Corp1.87%164,022$6.57MInstitution

1 of 3

TNXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNXP8.34%91.66%Net Buying
ALT37.18%62.82%Net SellingNet Buying
BNTC88.61%8.18%Net Buying
RCKT50.42%49.58%Net SellingNet Selling
LRMR49.28%50.72%Net BuyingNet Buying

Tonix Pharmaceuticals Holding Stock Ownership FAQ

Who owns Tonix Pharmaceuticals Holding?

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is owned by 15.94% institutional shareholders, 175.18% Tonix Pharmaceuticals Holding insiders, and 0.00% retail investors. Seth Lederman is the largest individual Tonix Pharmaceuticals Holding shareholder, owning 5.85M shares representing 66.72% of the company. Seth Lederman's Tonix Pharmaceuticals Holding shares are currently valued at $213.65M.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.